Provider groups are on task to create accountable care organizations (ACOs), and many believe they will change the delivery of healthcare
Provider groups are on task to create accountable care organizations (ACOs), and many observers believe they will change the delivery of healthcare in the next decade-although the degree of ACO impact is still greatly debated.
According to Chet Speed, VP, public policy for the American Medical Group Assn. (AMGA), ACOs' greatest potential is to shift the fragmented delivery system toward integration.
However, properly aligned incentives are essential to the success of ACOs. Ideally, it should ease providers away from fee for service.
However, Speed says that if the reimbursement formula is properly crafted, it will generate participation. In addition, there may be some interested parties who will wait until the ACO program has gone through a cycle of experience before joining.
"Over time, it seems likely that the model will evolve into one that employs alternative reimbursement mechanisms-such as partial capitation and bundled payments-and more completely rewards clinical outcomes successes," he says.
According to Speed, the private industry might determine the pathway to make ACOs work-ahead of Medicare. Payers will take advantage of the opportunities to hold providers more accountable for outcomes and quality, shifting a certain amount of financial risk onto the providers.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Positive Pipeline Updates for Friedreich’s Ataxia
October 24th 2024After experiencing setbacks, PTC reported positive results for vatiquinone, its selective inhibitor of 15-Lipoxygenase (15-LO) enzyme, regulator of the energetic and oxidative stress pathways that are disrupted in Friedreich ataxia
Read More